BCR and chronic myelogenous leukemia, BCR-ABL1 positive: These results suggest that the expression of DDX5 was induced not only by BCR-ABL, but also by the BCR-ABL T315I mutant, and that DDX5 was involved in cell proliferation and survival, even in CML cells resistant to BCR-ABL inhibitors.